The Powell Perspective

Amid record office vacancies, a 54,000 sq-ft lease at the iconic Transamerica Complex signals a strategic wager on the future of premium, flexible work.

Lundbeck completes enrollment for a pivotal trial testing a novel drug for severe childhood epilepsies. But what are the real stakes for patients and investors?

UAE's e& banks $5.95B from its Vodafone sale, refocusing on core assets. But as one giant exits, French telecom tycoon Xavier Niel enters the fray.

As PPL prepares its Q2 earnings, the utility stands at a crossroads of massive grid investment, soaring data center demand, and customer affordability.

Riverbed's recent industry nod isn't just a win; it's a signal. The age of autonomous IT is here, but its success hinges on one critical element: control.

A groundbreaking NEJM report shows Neutrolis's therapy rapidly reversed severe Lupus symptoms, validating a new, non-immunosuppressive approach.

Unlimited ETFs' AI-driven funds are posting top-tier returns, pulling in over $225M. But is this the future of accessible alts or a high-risk tech gambit?

A massive Texas expansion by Race Rock signals a critical shift. The private firm is betting on the urgent need to modernize North America's aging energy grid.

Conagra Brands slashed its dividend by 50%, calling it a 'reset.' We dissect if this is a prudent move to fund growth or a red flag for investors.

A new hospital designation promises safer surgical care for older adults. But what are the hidden costs for hospitals, and will it truly empower patients?

A new platform, XR ONE, claims its AI can end budget overruns and asset waste. Susan Powell investigates if this is actionable intelligence or just more digital noise.

Gentoo Media's appointment of Måns Svalborn signals a clear intent to accelerate its M&A strategy in a consolidating iGaming affiliate market.

As Yum China prepares its Q2 report, investors are watching for more than just sales figures. It's a crucial read on China's consumer health and digital future.

As Reddit prepares its Q2 2026 report, all eyes are on whether its explosive user growth and unique community can sustain its post-IPO financial success.

Rani Therapeutics partners with PegBio, betting its drug-injecting capsule can unlock novel oral obesity therapies and challenge market giants.

As cyber threats and regulations converge, EverLine's appointment of Jason Cradit as CTO/CISO signals a crucial shift toward integrated operational readiness.

A critical bottleneck in hardware validation is slowing innovation. Tektronix's new software unifies power and signal integrity analysis on a single platform.

Washing your car at home seems harmless, but it sends gallons of untreated pollutants into our waterways. Discover the hidden tech making professional car washes a smarter choice.

KlariVis is arming community banks with AI-driven insights once reserved for giants. Two new executive hires are leading the charge to democratize data.

While millions watch football, a growing number of adults are stuck on the sidelines. Carlsberg's new campaign tackles this inactivity crisis, but is it genuine social good or just savvy marketing?